1987 The clinical course of bone metastases from breast cancer. Br J Cancer 55:61–66. ,
1989 Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence. Br J Cancer 60:252–257. , ,
1986 Osteolytic metastases in breast carcinoma. Pathogenesis, morbidity and bisphosphonate treatment. Eur J Cancer Clin Oncol 22:493–500. , , , ,
1987 Bone metastases in breast cancer, prostate cancer and myeloma. Bone 8(Suppl 1):S17–S22.
1995 Tumor-bone interactions in skeletal metastasis. Clin Orthop 312:19–33. , , ,
1994 Osteolytic bone disease in breast cancer. Breast Cancer Res Treat 32:73–84. , ,
1993 Bone destruction in cancer. Semin Oncol 20:4–9.
1998 Cancer and bone. Endocr Rev 19:18–54. ,
1979 Chemotactic responses of tumor cells to products of resorbing bone. Science 203:176–179. , , , ,
1992 Stimulation of bone resorption results in a selective increase in growth rate of spontaneously metastatic Walker 256 cancer cells in bone. Clin Exp Metastasis 10:411–418. , , ,
1984 The Walker carcinosarcoma 256 as an experimental model of bone metastases; influence of local and metabolic factors on incidence and pattern of metastases. Calcif Tissue Int 36:S2.
1990 Chemotactic activity of bone and platelet TGFβ for bone metastasizing rat Walker carcinosarcoma cells. Invasion Metastasis 10:241–252. , ,
1988 A murine model of experimental metastasis to bone and bone marrow. Cancer Res 48:6876–6881. , ,
1995 Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res 55:3551–3557. , , , , , , ,
1996 Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest 98:1544–1549. , , , , , , ,
1997 Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2. J Clin Invest 99:2509–2517. , , , , , ,
1998 Osteoclasts are required for bone tumors to grow and destroy bone. Orthop Res 16:660–666. ,
1997 Parathyroid hormone-related protein and bone metastases. Cancer 80:1572–1580.
1999 Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology 140:4451–4458. , , , , , ,
1999 TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest 103:197–206. , , , , , , , ,
2000 Tumour progression and angiogenesis in bone metastasis from breast cancer: New approaches to an old problem. Cancer Treat Rev 26:11–27. , ,
1999 The emerging role of bisphosphonates in the prevention of bone metastases. TEM 10:24–29.
1998 Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption. Cancer Res 58:462–467. , , , , , ,
1974 Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 53:661–674. , , ,
1997 The role of angiogenesis and angiogenic factors in embryonic bone formation and resorption. A new model for bone angiogenesis. J Bone Miner Res 12:S313. , , ,
1995 A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine. J Histochem Cytochem 43:347–352. , ,
1991 Two distinct effects of recombinant human tumor necrosis factor-alpha on osteoclast development and subsequent resorption of mineralized matrix. Endocrinology 129:1596–1604. , , , , ,
1998 IL-1α, IL-1β, IL-6 and TNF-α steady-state mRNA levels analyzed by reverse transcription-competitive PCR in bone marrow of gonadectomized mice. J Bone Miner Res 13:185–194. , , ,
1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159. ,
1992 Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. J Biol Chem 267:21830–21838. , , , , , , ,
1993 An invitation to an open exchange of reagents and information useful for the measurement of cytokine mRNA levels by PCR. Eur Cytokine Networks 4:161–162.
1997 Perspective series: Cell adhesion in vascular biology. The biology of PECAM-1. J Clin Invest 99:3–8.
1991 Localization of parathyroid hormone-related protein in breast cancer metastases: Increased incidence in bone compared with other sites. Cancer Res 51:3059–3061. , , , , , , ,
1992 Localization of parathyroid hormone-related protein mRNA expression in breast cancer and metastatic lesions by in situ hybridization. J Bone Miner Res 7:971–979. , , , , , ,
1990 The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345:442–444. , , , , , , , ,
1990 Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology 127:2592–2594. , ,
1992 Effect of macrophage colony-stimulating factor on in vitro osteoclast generation and bone resorption. Endocrinology 130:437–442. , , , , ,
1971 Tumor angiogenesis: Therapeutic implications. N Engl J Med 285:1182–1186.
1997 Tumor angiogenesis: Functional similarities with tumor invasion. In: GoldbergID, RosenEM (eds.) Regulation of Angiogenesis, 1st ed. Birkhäuser Verlag, Basel, Switzerland, pp. 413–418. ,
1996 Patterns and emerging mechanisms of angiogenic switch during tumorigenesis. Cell 86:353–364. ,
1996 Reciprocal paracrine interactions between tumour cells and endothelial cells: The ‘angiogenesis progression’ hypothesis. Eur J Cancer 32A:2438–2450. , ,
1989 What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4–6.
1991 Tumor angiogenesis and metastases—correlation in invasive breast carcinoma. N Engl J Med 324:1–6. , , ,
1996 Breast cancer angiogenesis—new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targeting. Breast Cancer Res Treat 38:97–108. , , , , , , , ,
1998 Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients. J Clin Oncol 16:3129–3136. , , , , , , , , , , , ,
1999 Breast carcinoma: Vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res 59:856–861. , , , , , ,
1998 Prognostic value of angiogenesis in mammary tumors. AntiCancer Res 18:2199–2202. , , , , ,
1995 Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat 36:193–204. , , ,
1998 Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis. Breast Cancer Res Treat 52:147–158. , , ,
1998 Clinical significance of angiogenic factors in breast cancer. Breast Cancer Res Treat 52:159–173. , ,
1997 The biology of vascular endothelial growth factor. Endocr Rev 18:4–25. ,
1999 Vascular endothelial growth factor (VEGF) and its receptors. FASEB 13:9–22. , , ,
1997 Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal endothelial cells. Oncogene 14:2025–2032. , , , ,
1992 Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest 89:244–253. , , , ,
1992 The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989–991. , , , , ,
1993 Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 90:7533–7537. , , , ,
1996 Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 93:2576–2581. , , , , , , , , ,
1998 VEGF-B binds to VEGFR-1, and regulates plasminogen activator activity in endothelial cells. Proc Natl Acad Sci USA 95:11709–11714. , , , , , , , , , ,
1996 A novel vascular endothelial growth factor, VEGF-C is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:290–298. , , , , , , , ,
1999 VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 154:1381–1390. , , , , , , , , ,
1997 TGF beta-1 regulation of VEGF production by breast cancer cells. Ann Surg Oncol 4:621–627. , , , , ,